Summary
The problem of pathogenic antibiotic-resistant bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa is worsening, demonstrating the urgent need for new therapeutics that are effective against multidrug-resistant bacteria. One potential class of substances is cationic antimicrobial peptides. More than 1000 natural occurring peptides have been described so far. These peptides are short (less than 50 amino acids long), cationic, amphiphilic, demonstrate different three-dimensional structures, and appear to have different modes of action. A new screening assay was developed to characterize and optimize short antimicrobial peptides. This assay is based on peptides synthesized on cellulose, combined with a bacterium, where a luminescence gene cassette was introduced. With help of this method tens of thousands of peptides can be screened per year. Information gained by this high-throughput screening can be used in quantitative structure-activity relationships (QSAR) analysis. QSAR analysis attempts to correlate chemical structure to measurement of biological activity using statistical methods. QSAR modeling of antimicrobial peptides to date has been based on predicting differences between peptides that are highly similar. The studies have largely addressed differences in lactoferricin and protegrin derivatives or similar de novo peptides. The mathematical models used to relate the QSAR descriptors to biological activity have been linear models such as principle component analysis or multivariate linear regression. However, with the development of high-throughput peptide synthesis and an antibacterial activity assay, the numbers of peptides and sequence diversity able to be studied have increased dramatically. Also, “inductive” QSAR descriptors have been recently developed to accurately distinguish active from inactive drug-like activity in small compounds. “Inductive” QSAR in combination with more complex mathematical modeling algorithms such as artificial neural networks (ANNs) may yield powerful new methods for in silico identification of novel antimicrobial peptides.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hancock, R.E.W. and Lehrer, R. (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16, 82–88.
Finking, R. and Marahiel, M.A. (2004) Biosynthesis of nonribosomal peptides. Annu. Rev. Microbiol. 58, 453–488.
Garcia-Olmedo, F., Molina, A., Alamillo J.M., and Rodriguez-Palenzuela P. (1998) Plant defense peptides. Biopolymers 47, 479–491.
Kawabata, S., Beisel, H.G., Huber, R., et al. (2001) Role of tachylectins in host defense of the Japanese horseshoe crab Tachypleus tridentatus. Adv. Exp. Med. Biol. 484, 195–202.
Bulet, P., Stocklin, R. and Menin, L. (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198, 169–184.
Iwanaga, S. and Kawabata, S. (1998) Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab. Front. Biosci. 3 D973–D984.
Imler, J.L. and Bulet, P. (2005) Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Chem. Immunol. Allergy 86, 1–21.
Cannon, J.P., Haire, R.N. and Litman G.W. (2002) Identification of diversified genes that contain immunoglobulin-like variable regions in a protochordate. Nat. Immunol. 3, 1200–1207.
Litman, G.W., Anderson, M.K. and Rast, J.P. (1999) Evolution of antigen binding receptors. Annu. Rev. Immunol. 17, 109–147.
Nochi, T. and Kiyono, H. (2006) Innate immunity in the mucosal immune system. Curr. Pharm. Des. 12, 4203–4213.
Yang, D., Biragyn, A., Hoover, D.M., Lubkowski, J. and Oppenheim, J.J. (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22, 181–215.
Li, J., Xu, X., Xu, C., et al. (2007) Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteomics. Epub ahead of print, Jan 31, 2007.
Yang, D., Biragyn, A., Kwak, L.W. and Oppenheim, J.J. (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291–296.
Jenssen, H., Hamill, P. and Hancock, R.E.W. (2006) Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491–511.
Papo, N. and Shai, Y. (2005) Host defense peptides as new weapons in cancer treatment. Cell. Mol. Life Sci. 62, 784–790.
Gallo, R.L., Ono, M., Povsic, T., et al. (1994) Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 91, 11035–11039.
Hancock, R.E.W. and Rozek, A. (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206, 143–149.
Mani, R., Cady, S.D., Tang, M., Waring, A.J., Lehrer, R.I. and Hong, M. (2006) Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc. Natl. Acad. Sci. USA 103, 16242–16247.
Hwang, P.M. and Vogel, H.J. (1998) Structure-function relationships of antimicrobial peptides. Biochem. Cell. Biol. 76, 235–246.
Gazit, E., Miller, I.R., Biggin, P.C., Sansom, M.S.P., and Shai, Y. (1996) Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. J. Mol. Biol. 258, 860–870.
Brogden, K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238–250.
Paschke, M. (2006) Phage display systems and their applications. Appl. Microbiol. Biotechnol. 70, 2–11.
Westerlund-Wikstrom, B. (2000) Peptide display on bacterial flagella: principles and applications. Int. J. Med. Microbiol. 290, 223–230.
Yan, X. and Xu, Z. (2006) Ribosome-display technology: applications for directed evolution of functional proteins. Drug Discov. Today 11, 911–916.
Pini, A., Giuliani, A., Falciani, C., et al. (2005) Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob. Agents Chemother. 49, 2665–2672.
Xie, Q., Matsunaga, S., Wen, Z., et al. (2006) In vitro system for high-throughput screening of random peptide libraries for antimicrobial peptides that recognize bacterial membranes. J. Pept. Sci. 12, 643–652.
Houghten, R.A. (1985) General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82, 5131–5135.
Pellois, J.P., Zhou, X., Srivannavit, O., Zhou, T., Gulari, E. and Gao, X. (2002) Individually addressable parallel peptide synthesis on microchips. Nat. Biotechnol. 20, 922–926.
Geysen, H.M., Meloen, R.H. and Barteling, S.J. (1984) Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA 81, 3998–4002.
Frank, R. (1992) Spot synthesis: an easy technique for positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48, 9217–9232.
Hilpert, K. and Hancock, R.E.W. (2007) Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose by peptide array technology. Nature Protocols, 3, 1652–1660.
Kamradt, T. and Volkmer-Engert, R. (2004) Cross-reactivity of T lymphocyctes in infection and autoimmunity. Mol. Divers. 8, 271–280.
Hilpert, K., Winkler, F.H.D. and Hancock, R.E.W. (2007) Peptide arrays on cellulose support: SPOT synthesis - a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nature Protocols, 2,1333–1349.
Lewenza, S., Falsafi, R.K., Winsor, G., et al. (2005) Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res. 15, 583–589.
Hilpert, K., Volkmer-Engert, R., Walter, T. and Hancock, R.E.W. (2005) High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23, 1008–1012.
Hilpert, K., Elliott, M.R., Volkmer-Engert, R., et al. (2006) Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem. Biol. 13,1101–1107.
Gennaro, R., Skerlavaj, B., and Romeo, D. (1989) Purification, composition and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect. Immun. 57, 3142–3146.
Scocchi, M., Romeo, D., and Zanetti, M. (1994) Molecular cloning of Bac7, a praline- and arginine-rich antimicrobial peptide from bovine neutrophils. FEBS Lett. 352, 197–200.
Wu, M. and Hancock, R.E.W. (1999) Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob. Agents Chemother. 43, 1274–1276.
Moore, A.J., Beazley, W.D., Bibby, M.C. and Devine, D.A. (1996) Antimicrobial activity of cecropins. J Antimicrob. Chemother. 37, 1077–1089.
Sipos, D., Andersson, M., and Ehrenberk, A. (1992) The structure of the mammalian antibacterial peptides cecropin P1 in solution, determined by proton-NMR. Eur. J. Biochem. 209, 163–169.
Turner, J., Cho, Y., Dinh, N.N., Waring, A.J., and Lehrer, R.I. (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206–2214.
Zimmermann, G.R., Legault, P., Selsted, M.E. and Pardi, A. (1995) Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. Biochemistry 34, 13663–13671.
Mandal, M., Jagannadham, M.V. and Nagaraj, R. (2001) Antibacterial activities and conformations of bovine β-defensin BNBD-12 and analogs: structural and disulfide bridge requirements for activity. Peptides 23, 413–418.
Lee, D.L., and Hodges, R.S. (2003) Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on Gramicidin S. Biopolymers 71,28–48.
Wadhwani, P., Afonin, S., Ieronima, M., Buerck, J., and Ulrich, A.S. (2006) Optimizad protocol for síntesis of cyclic Gramicidin S: starting amino acid is key to high yield. J. Org. Chem . 71, 55–61.
Ryge, T.S., Doisy, X., Ifrah, D., Olsen, J.E., and Hansen, P.R. (2004) New indolicidin analogues with potent antibacterial activity. J. Pept. Res. 64, 171–185.
Selsted, M.E., Tang, Y.-Q., Morris, W.L., et al. (1993) Purification, primary structures, and antibacterial activities of b-defensins, a new family of antimicrobial peptides from bovine neutrophils. J. Biol. Chem. 268, 6641–6648.
Samuelsen ,O., Haukland, H.H., Ulvatne, H. and Vorland, L.H. (2004) Anti-complement effects of lactoferrin-derived peptides. FEMS Immunol. Med. Microbiol. 41, 141–148.
Chen, H.-L., Yen, C.-C., Lu, C.-Y., Yu, C.-H., and Chen, C.-M. (2006) Synthetic porcine lactoferricin with a 20 residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans. J. Agric. Food Chem. 54, 3277–3282.
Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S., et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A streptococcus. J. Invest. Dermatol. 117, 91–97.
Gudmundsson, G.M., Lidholm, D.-A., Åsling, B., Gan, R., and Boman, H.G. (1991) The cecropin locus. Cloning and expression of a gene cluster encoding three antibacterial peptides in Hyalaphora cecropia. J. Biol. Chem. 266, 11510–11517.
Gesell, J., Zasloff, M. and Opella, S.J. (1997) Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J. Biomol. NMR 9, 127–135.
Wei, G., Campagna, A.N. and Bobek, L.A. (2006) Effects of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J. Antimicrob. Chemother. 57, 1100–1109.
Giacometti, A., Cirioni, O., Barchiesi, F., Del Prete, M.S. and Scalise G. (1999). Antimicrobial activity of polycationic peptides. Peptide 20, 1265–1273.
Giacometti, A., Cirioni, O., Barchiesi, F., Fortuna, M., and Scalise, G. (1999) In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44, 641–645.
Olasupo, N.A., Fitzgerald, D.J., Gasson, M.J., and Narbad, A. (2003) Activity of natural antimicrobial compounds against Escherichia coli and Salmonella enterica serovar Typhimurium. Lett. Appl. Microbiol. 36, 448–451.
van den Hooven, H.W., Doeland, C.C.M., van de Kamp, M., Konings, R.N.H., Hilbers, C.W., and van de Ven, F.J.M. (1996) Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of dodecylsulphate. Eur. J. Biochem. 235, 382–393.
Clausell, A., Rabanal, F., Garcia-Subirats, M., Alsina, M.A., and Cajal, Y. (2005) Synthesis and membrane action of polymyxin B analogues. Luminescence. 20,117–123.
Li, C., Lewis, M.R., Gilbert, A.B., et al. (1999) Antimicrobial activities of amine- and guanidine- functionalized cholic acid derivatives. Antimicrob. Agents Chemother. 43, 1347–1349.
Regna, P.P., Solomons, I.A., Forscher, B.K., and Timreck, A.E. (1949) Chemical studies on polymyxin B. J. Clin. Invest. 28, 1022–1027.
Agerberth, B., Lee, J.Y., Bergman, T., et al. (1991) Amino acid sequence of PR-39, isolation from pig intestine of a new member of the family of Pro, Arg, rich antibacterial peptides. Eur. J. Biochem. 202, 849–854.
Shi, J., Ross, C.R., Chengappa, M.M., Sylte, M.J., McVey, D.S., and Blecha, F. (1996) Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a praline-arginine-rich neutrophil antimicrobial peptide. Antimicrob. Agents Chemother. 40, 115–121.
Aumelas, A., Mangoni, M., Roumestand, C., et al. (1996) Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur. J. Biochem. 237, 575–583.
Fahrner, R.L, Dieckmann, T., Harwig, S.S.L., Lehrer, R.I., Eisenberg, D., and Feigon, J. (1996) Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. (London) 3, 543–550.
Steinberg, D.A., Hurst, M.A., Jufii, C.A., et al. (1997) Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41, 1738–1742.
Kawano, K., Yoneya, T., Miyata, T., et al. (1990) Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus). J. Biol. Chem. 265, 15365–15367.
Nakamura, T., Furunaka, H., Miyata, T., Tokunaga, F., Muta, T., and Iwanaga, S. (1988) Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horshoe crab (Tachypleus tridentatus). J. Biol. Chem. 263, 16709–16713.
Perkins, R., Fang, H., Tong, W., and Welsh, W.J. (2003) Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology. Environ. Toxicol. Chem. 22, 1666–1679.
Weaver, D.C. (2004). Applying data mining techniques to library design, lead generation and lead optimization. Curr. Opin. Chem. Biol. 8, 264–270.
Lejon, T., Strom, M.B., and Svendsen, J.S. (2001) Antibiotic activity of pentadecapeptides modelled from amino acid descriptors. J. Pept. Sci. 7, 74–81.
Lejon, T., Stiberg, T., Strom, M.B., and Svendsen, J.S. (2004) Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins. J. Pept. Sci. 10, 329–335.
Strom, M.B., Stensen, W., Svendsen, J.S., and Rekdal, O. (2001) Increased antibacterial activity of 15-residue murine lactoferricin derivatives. J. Pept. Res. 57,127–139.
Jenssen, H., Gutteberg, T.J., and Lejon, T. (2005) Modeling of anti-HSV activity of lactoferricin analogues using amino acid descriptors. J. Pept. Sci. 11, 97–103.
Hellberg, S., Sjostrom, M., Skagerberg, B., and Wold, S. (1987) Peptide quantitative structure-activity relationships, a multivariate approach. J. Med.Chem. 301126–1135.
Frecer, V., Ho, B., and Ding, J.L. (2004) De novo design of potent antimicrobial peptides. Antimicrob. Agents Chemother. 48, 3349–3357.
Frece, V. (2006) QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1. Bioorgan. Medic. Chem. 14, 6065–6074.
Ostberg, N., and Kaznessis, Y. (2004) Protegrin structure–activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides 26, 197–206.
Cherkasov, A. (2005) Inductive QSAR descriptors. Distinguishing compounds with antibacterial activity by artificial neural networks. Int. J. Mol. Sci. 6, 63–86.
Cherkasov, A. (2005) ‘Inductive’ descriptors. 10 successful years in QSAR. Curr. Computer-Aided Drug Design 1, 21–42.
Cherkasov, A. (2003) Inductive electronegativity scale. Iterative calculation of inductive partial charges. J. Chem. Inf. Comp. Sci. 43, 2039–2047.
Cherkasov, A., Shi, Z., Fallahi, M., and Hammond, G.L. (2005) Successful in silico discovery of novel non-steroidal ligands for human sex hormone binding globulin. J. Med. Chem. 48, 3203–3213.
Karakoc, E., Sahinalp, S.C., and Cherkasov, A. (2006) Comparative QSAR- and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds. J. Chem. Inf. Model. 46, 2167–2182.
Karakoc, E., Cherkasov, A., and Sahinalp, S.C. (2006) Distance based algorithms for small biomolecule classification and structural similarity search. Bioinformatics 15, 243–251.
Molecular Operational Environment. (2004) Chemical Computation Group Inc., Montreal, Canada.
SNNS: Stuttgart Neural Network Simulator, version 4.2, from University of Tübingen, Stuttgart, Germany. Available at http://www-ra.informatik.uni-tuebingen.de/SNNS/.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Hilpert, K., Fjell, C.D., Cherkasov, A. (2008). Short Linear Cationic Antimicrobial Peptides: Screening, Optimizing, and Prediction. In: Otvos, L. (eds) Peptide-Based Drug Design. Methods In Molecular Biology™, vol 494. Humana Press. https://doi.org/10.1007/978-1-59745-419-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-419-3_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-990-1
Online ISBN: 978-1-59745-419-3
eBook Packages: Springer Protocols